Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for COR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 2.654B
March 31, 2026 1.339B
December 31, 2025 -2.305B
September 30, 2025 3.133B
June 30, 2025 109.25M
March 31, 2025 3.351B
December 31, 2024 -2.719B
September 30, 2024 1.000B
June 30, 2024 2.478B
March 31, 2024 -878.44M
December 31, 2023 885.16M
September 30, 2023 1.827B
June 30, 2023 744.94M
March 31, 2023 629.51M
December 31, 2022 710.08M
September 30, 2022 1.164B
June 30, 2022 408.62M
March 31, 2022 266.58M
December 31, 2021 863.41M
September 30, 2021 1.010B
June 30, 2021 1.208B
March 31, 2021 -453.90M
December 31, 2020 903.05M
September 30, 2020 1.299B
June 30, 2020 -87.90M
Date Value
March 31, 2020 852.90M
December 31, 2019 142.81M
September 30, 2019 672.82M
June 30, 2019 567.87M
March 31, 2019 624.36M
December 31, 2018 478.97M
September 30, 2018 665.34M
June 30, 2018 823.28M
March 31, 2018 -87.57M
December 31, 2017 10.33M
September 30, 2017 1.380B
June 30, 2017 -244.70M
March 31, 2017 798.74M
December 31, 2016 -430.36M
September 30, 2016 1.357B
June 30, 2016 189.94M
March 31, 2016 880.41M
December 31, 2015 751.61M
September 30, 2015 1.162B
June 30, 2015 1.122B
March 31, 2015 741.72M
December 31, 2014 896.96M
September 30, 2014 830.66M
June 30, 2014 519.84M
March 31, 2014 1.116B

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Cardinal Health, Inc. 1.692B
McKesson Corp. -220.00M
CVS Health Corp. 6.345B
Henry Schein, Inc. 242.00M
Accendra Health, Inc. -26.01M